Commenting on the appointment, Yashna Garg, Founder, Yugap Wellness, said, “Dr. Satish Singh’s deep healthcare and pharmaceutical expertise, combined with his regulatory leadership, will play a pivotal role in strengthening our scientific direction. His experience across medicines, nutraceuticals, and food systems aligns strongly with our vision of building wellness solutions grounded in science and trust.”

With over 18 years of experience in healthcare, pharmaceuticals, nutraceuticals, food, and Ayurveda, Dr. Singh has led quality assurance, regulatory affairs, and compliance across some of India’s leading healthcare organizations, including Zeon Lifesciences, Patanjali Ayurved, Hamdard Laboratories, Torrent Pharmaceuticals, Maiden Pharmaceuticals, and Ranbaxy Fine Chemicals. A Ph.D. in Pharmaceutical Sciences, he has overseen global regulatory audits, product validations, and quality systems across therapeutic formulations, dietary supplements, and functional foods, working closely with regulators such as USFDA, Natural and Non-prescription Health Products Directorate, Canada (NNHPD), FSSAI, AYUSH, and international health authorities.

Dr. Singh’s appointment reinforces Yugap Wellness’ commitment to integrating healthcare-grade quality, rigorous regulatory compliance, and scientific credibility into every aspect of its product development, ensuring consumers receive wellness solutions that meet global healthcare and safety benchmarks.

The post Yugap Wellness appoints Dr. Satish Singh as Board Member- Scientific Committee appeared first on Business of Food.